Asistencia ventricular de larga duración en España (2007-2020). I informe del registro REGALAD

Gómez‐Bueno, Manuel; Sota, Enrique Pérez de la; Gil, Alberto; Ortiz-Berbel, Daniel; Castrodeza, Javier; Carmena, María Dolores García-Cosío; Barge‐Caballero, Eduardo; Sousa, Diego Rangel; Molina, Beatriz Díaz; Antón, Rebeca Manrique; Almenar‐Bonet, Luis; González, Aitor Uribarri; Barrio-Rodríguez, Alfredo; Lavilla, María Ángeles Castel; López-López, Laura; Pérez, David Dobarro; Pérez, Francisco Pastor; Burgos-Palacios, Virginia; Álvarez‐García, Jesús; Garrido-Jiménez, José Manuel; González-Fernández, Óscar; Codina, Pau; López‐Granados, Amador; Grau-Sepulveda, Andrés; González‐Costello, José

doi:10.1016/j.recesp.2022.07.001

Cited by 7 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The 30-day readmission rate is 20% [1], remaining the leading cause of hospitalization among patients ≥ 65 years old, and the third cause of cardiovascular mortality accounting up to 20%. Also, 55-70% of patients die within 5 years of diagnosis with a mortality rate of 20% per year, 50% at 5 years, and up to 80% at 10 years [8][9][10][11][12][13][14][15][16][17][18][19]. Each new hospitalization increases the mortality risk of these patients by 20%, so avoiding severe decompensation is considered crucial.…”

Section: Introductionmentioning

confidence: 99%

Prognostic Significance of Lung Ultrasound for Heart Failure Patient Management in Primary Care: A Systematic Review

Panisello-Tafalla,

Haro-Montoya,

Caballol-Angelats

et al. 2024

JCM

View full text Add to dashboard Cite

Background: Heart failure (HF) affects around 60 million individuals worldwide. The primary aim of this study was to evaluate the efficacy of lung ultrasound (LUS) in managing HF with the goal of reducing hospital readmission rates. Methods: A systematic search was conducted on PubMed, Embase, Google Scholar, Web of Science, and Scopus, covering clinical trials, meta-analyses, systematic reviews, and original articles published between 1 January 2019 and 31 December 2023, focusing on LUS for HF assessment in out-patient settings. There is a potential for bias as the effectiveness of interventions may vary depending on the individuals administering them. Results: The PRISMA method synthesized the findings. Out of 873 articles identified, 33 were selected: 19 articles focused on prognostic assessment of HF, 11 centred on multimodal diagnostic assessments, and two addressed therapeutic guidance for HF diagnosis. LUS demonstrates advantages in detecting subclinical congestion, which holds prognostic significance for readmission and mortality during out-patient follow-up post-hospital-discharge, especially in complex scenarios, but there is a lack of standardization. Conclusions: there are considerable uncertainties in their interpretation and monitoring changes. The need for an updated international consensus on the use of LUS seems obvious.

show abstract